工频磁场对星形胶质细胞间隙连接通讯功能的影响

目的　探讨工频磁场 (PFMF)是否有促癌或协同促癌作用。方法　利用荧光光漂白后再恢复法观察漂白细胞荧光强度的恢复以判断经间隙连接的细胞间通讯 ,以相对荧光强度恢复速率(CFIRR)作为对细胞间隙连接通讯 (GJIC)作用的评价指标 ,研究不同磁场强度单独作用或协同佛波酯(TPA)对星形胶质细胞GJIC功能的影响。结果　 3ng/mlTPA作用 1h时CFIRR的中位数 (Md)值为4 .53 % /min ,空白对照组为 9.74% /min ,两组的差异有显著性 (H =1 2 .0 84,P <0 .0 0 5)。 0 .8或 1 .6mT磁场作用 2 4h时CFIRR的Md 分别 8.2 5、6 .68% /min ,与空白对照组比较 ,差异无显著性 (H =32 .61 7,P >0 .0 5)。 0 .8或 1 .6mT磁场作用 2 3h ,再与TPA共同作用 1h时CFIRR的Md 分别为 3 .32、2 .85% /min ,与TPA组比较 ,差异无显著性 (H =2 .589,P >0 .0 5)。结论　 0～ 1 .6mT的 50Hz磁场单独作用不能抑制星形胶质细胞GJIC功能 ;协同TPA ,不能增强TPA对星形胶质细胞GJIC的抑制作用 ;但是磁场对星形胶质细胞GJIC的抑制作用随着磁场强度增强呈递增趋势     

99Tcm直接法标记血管抑素

目的: 探索用99Tcm直接标记血管抑素(angiostatin, AS)的方法,并研究标记产物的体外稳定性及其生物活性. 方法:制备的AS经鉴定后,分别用2-巯基乙醇(2-ME)和氯化亚锡(SnCl2)还原法进行标记,并用正交设计筛选最佳合成条件;对标记产物用纸层析法及Sephadex G-50层析柱分离测标记率;产物中分别加入牛血清白蛋白(BSA)、生理盐水及不同摩尔比的半胱氨酸(Cys)以观察其体外稳定性;用人脐静脉内皮细胞系ECV304观察其生物活性. 结果:2-ME法最佳标记条件为AS 100 μg,PB(0.5 mol*L-1, pH 7.3) 1 mL, 2-ME 100 μg, 亚甲基二膦酸盐(MDP)(用1 mL生理盐水溶解) 10 μL,加入99TcmO4- 185 MBq,标记率可达(97.0±1.5)%; SnCl2法为AS 100 μg,硼酸缓冲液(0.1 mol*L-1, pH 9.0) 1 mL, 20 g*L-1 SnCl2 (1 mol*L-1盐酸作为溶剂) 20 μL加入MDP药盒,用去氧水稀释至1 mL, 取20 μL,加入99TcmO4- 185 MBq,标记率可达(90.0±3.0)%. 产物在体外稳定;细胞培养观察其抑制内皮细胞生物活性与AS无显著差异. 结论:用99Tcm直接法标记AS简单高效,且对AS生物活性无明显影响.     

喉部CT仿真内窥镜成像技术的探讨

目的：探讨喉部CT仿真内窥镜(CT virtual endoscopy，CTVE)的成像质量及其影响因素。方法：对84例喉部螺旋CT扫描者行CTVE成像，根据喉腔内部结构、病灶、黏膜皱襞的显示情况和有无伪影将CTVE图像分为3级，分别比较CTVE技术在不同的扫描层厚、重建层厚及阈值的情况下图像质量的优劣。结果：CT原始扫描层厚为2mm、3mm分别与5mm、8mm的CTVE图像质量相比较，有显著性差异(P＜0．05)；重建层厚为2mm、3mm与5mm相比较，均有显著性差异(P＜0．05)；阈值为 -800— -600HU与阈值为-300HU相比较，有显著性差异(P＜0．05)。结论：不同的CT原始扫描层厚、重建层厚及阈值对CTVE图像的质量影响有明显差异。选用合适的原始扫描参数及重建参数，可以提高CTVE图像的质量，对喉部疾病的诊断很有帮助。     

浅议高中生物教师“三种意识”的确立

在建设学习型社会和新课改的新形势下,高中生物教师应确立三种意识:"学习意识、信息意识、科研意识",不断提高自身素质,使自己成为一名学者型、研究型的现代生物教师.     

Type 1 protein tyrosine kinases in benign and malignant breast lesions

Aims : To determine their significance, we examined the expression pattern of the four epidermal growth factor receptor (EGFR) family members as well as the phosphotyrosine kinase activity in breast tumour tissues.  

Methods and results

Fifty-three malignant breast tumours, four breast cancer cell lines, and 10 benign breast tumours were investigated. Fifty-three per cent (28/53) of the malignant tumours expressed EGFR protein, and the majority of these positive tumours were strongly positive. Eighty per cent (8/10) of the benign tumours also expressed EGFR protein, but all in a lower or moderate level. An association between EGFR expression and increasing malignancy grade was found in the group of infiltrating ductal carcinomas. Of the malignant tumours, 35.8% (19/53) expressed c-erbB-2 protein and 17% (9/53) c-erbB-3 protein, while no expression of c-erbB-2 and c-erbB-3 proteins was found in the benign tumours. Contrary to previous reports, we observed c-erbB-4 receptor protein to be less expressed in the malignant breast tumours. The 'normal' breast epithelial cells adjacent to the malignant tumours and the benign tumours demonstrated intensified membrane staining for c-erbB-4, while a number of the malignant tumours demonstrated a weak cytoplasmic staining or were negative. However, several malignant tumours with strong membrane staining for the c-erbB-4 protein were also found. No simple association between the expression of the four receptors and phosphotyrosine kinase activity was found.  

Conclusion

Our study has revealed a complex expression pattern of the EGFR family members in breast tumour cells. While the data about EGFR, c-erbB-2, c-erbB-3 and phosphotyrosine are largely in line with what has been reported, we found the c-erbB-4 protein expression to be decreased in the malignant tumours.     

CD44+/CD24-细胞在乳腺癌组织及细胞系中的数量与分布

Objective To study the distribution and quantity of CD44VCD24- cells in breast cancer tissue and the cell lines,and as well as its correlation with the expression of various breast cancer markers and molecular subtyping of breast carcinoma.Methods The expression of CD44 / CD24,estrogen receptor,progesterone receptor,HER2,human estrogen-induced protein PS2,bcl-2 and nm23 in 60 cases of invasive ductal carcinoma of breast were studied by either single or double immunohistochemical staining.The co-expression of CD44 and CD24 in 3 breast cancer cell lines (MCF-7,MDA-MB-468,and MDA-MB- 231) was also examined.Results The quantity and distribution of CD44 + /CD24- cells varied greatly and no specific patterns were identified.The percentage of CD44 + /CD24- in breast cancer was 65%.The amount of CD44+/CD24- cells did not correlate with the age of patients,lymph node metastasis,tumor　 size,molecular subtypes and expression of various breast cancer markers in breast carcinoma.The proportion of CD44+/CD24- cells in MCF-7,MDA-MB-468,and MDA-MB-231 cell lines was < 1%,5% and > 80% ,respectively.Conclusions CD44+ /CD24- cells are demonstrated in certain breast cancer tissues and cell lines.However,there is no relationship obtained between the quantity or the distribution of these cells and the molecular subtyping or the clinicopathologic parameters in breast cancer.     

Apolipoprotein B-100 gene Xba I polymorphism and cholesterol gallstone disease

The apolipoprotein (apo) B gene Xba I polymorphism is associated with alterations in serum lipids. Disturbances in serum lipids may be a risk factor for cholesterol gallstone disease. However, the relation between the Xba I polymorphism and cholesterol gallstones is unknown. This study was aimed at characterizing the polymorphism of the apo B gene Xba I in patients with gallbladder stones and the association of Xba I polymorphism with serum lipids. Xba I genotypes were measured by PCR-RFLP, and serum lipids assayed in 190 patients with gallbladder stones and 441 control subjects. The frequency of the X+/- genotype (20.63 vs. 7.94%) and X+ allele (10.79 vs. 3.97%) was significantly higher in the patient group than in the control group. Patients with the X+/- genotype had a significantly higher concentration of total cholesterol, low-density lipoprotein (LDL)-cholesterol, and apo B in serum than patients with the X-/- genotype. The X+ allele of the apo B gene is characterized by a higher cholesterol concentration and a higher LDL-cholesterol concentration in serum, and it may be a marker for increased risk of cholesterol gallstone disease.     

北京市胎儿及婴儿先天性脑积水发生情况及婴儿期转归

目的通过对北京市5年先天性脑积水(CH)监测资料分析,了解北京市胎儿及婴儿的CH发生率、诊断及转归。 方法选择2015年1月至2019年12月,北京市出生缺陷监测系统内监测对象(胎龄为13周至生后1岁)中,407例CH患儿(胎儿或婴儿)为研究对象。对其出生缺陷诊断资料进行分析。采用χ²检验,对孤立性与非孤立性CH活产儿婴儿期存活率进行统计学比较。本研究遵循的程序符合2013年新修订的《世界医学协会赫尔辛基宣言》要求。 结果本研究时间(5年)内,北京市胎儿及1岁内婴儿的CH发生率为3.60×10^-4(407/1 129 861)。这407例CH患儿中,82例(20.15%)合并颅外畸形,20例(4.91%)合并染色体异常;CH胎儿的产前诊断率为92.38%(376/407),超声检出CH胎儿时,其胎龄为24周(23~35周),其中胎龄≥28周者占26.06%(98/376)。376例产前被诊断的CH胎儿中,44例采取产前胎儿超声联合MRI检查,而且通过胎儿MRI检查对4例胎儿的颅内畸形具体类型进行了补充诊断。本研究未发现CH患儿的孕母合并宫内感染;103例CH活产儿中,73例孤立性CH患儿的婴儿期(1岁内)存活率为72.6%(53/73),高于30例非孤立性CH患儿的婴儿期存活率(60.0%,18/30),二者比较,差异无统计学意义(P>0.05)。 结论北京市在预防出生缺陷发生的三级防控体系中,对CH胎儿与婴儿的一级、二级防控已取得效果。对孕妇全孕期多次动态胎儿超声检查,必要时联合胎儿MRI检查,对非孤立性CH胎儿同时采取细胞遗传学和分子遗传学检测,可进一步提高CH患儿的防控效果。     

儿童期的骨生长代谢研究

目的　探讨儿童期骨生长代谢的变化规律。方法　对成都市城区 2 2 4名 3～ 15岁健康儿童的骨生化指标、腰椎骨密度及跟骨骨小梁进行了检测和分析。结果　儿童期血清钙、磷和尿钙、磷在各年龄段无统计学上的差异 (P>0 .0 5 ) ;血清碱性磷酸酶 (AL P)及骨碱性磷酸酶 (BAL P)随年龄增长而增高 ,7～ 12岁时达到高峰 ,儿童期 AL P、BAL P明显高于成人 (P<0 .0 5 )。腰椎骨密度及跟骨骨小梁随年龄增长而增加。结论　儿童期反映骨生长代谢的生化指标、骨密度、跟骨骨小梁有其自身的变化规律 ,不能以成人的指标作为判断标准 ,而应采用儿童期的骨生长代谢指标来诊断和治疗儿童骨代谢性疾病     

Fractionated carbon dioxide (CO2) laser treatment contributes to trans-nail penetration of rhodamine B and changes of cytokine microenvironment

Lasers in Medical Science - This study is to determine the role of the fractional CO2 laser in topical drug delivery and the impact of local immune responses. Experimental rabbit nails were treated...